世界の細菌性膣炎治療薬市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Bacterial Vaginosis Therapeutics Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-5094
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、109ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療機器

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、細菌性膣炎治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（医薬品、手術、その他）、用途別市場規模（病院、診療所、診断研究所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・細菌性膣炎治療薬の市場動向
・企業の競争状況、市場シェア
・細菌性膣炎治療薬の種類別市場規模と予測2016-2027（医薬品、手術、その他）
・細菌性膣炎治療薬の用途別市場規模と予測2016-2027（病院、診療所、診断研究所、その他）
・細菌性膣炎治療薬の北米市場規模2016-2027（アメリカ、カナダ）
・細菌性膣炎治療薬の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・細菌性膣炎治療薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・細菌性膣炎治療薬の中南米市場規模2016-2027（メキシコ、ブラジル）
・細菌性膣炎治療薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Pfizer、Merck、Novartis、Lupin Pharmaceuticals、Symbiomix Therapeutics、Mission Pharmacal Company、Bayer、Sanofi、Starpharma Holdings、Alfa Wassermann、AmVac、Evofem、Osel）
・結論

Bacterial vaginosis is an infection characterised by overgrowth of anaerobic bacteria in the vagina with an accompanying loss of lactobacilli.

Market Analysis and Insights: Global Bacterial Vaginosis Therapeutics Market
The global Bacterial Vaginosis Therapeutics market size is projected to reach US$ 1586.3 million by 2027, from US$ 940.1 million in 2020, at a CAGR of 7.3% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Bacterial Vaginosis Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Bacterial Vaginosis Therapeutics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Bacterial Vaginosis Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Bacterial Vaginosis Therapeutics market.

Global Bacterial Vaginosis Therapeutics Scope and Market Size
Bacterial Vaginosis Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Bacterial Vaginosis Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Medicine
Surgery
Other

Segment by Application
Hospitals
Clinics
Diagnostic Laboratories
Other

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Pfizer
Merck
Novartis
Lupin Pharmaceuticals
Symbiomix Therapeutics
Mission Pharmacal Company
Bayer
Sanofi
Starpharma Holdings
Alfa Wassermann
AmVac
Evofem
Osel

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Bacterial Vaginosis Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Medicine
1.2.3 Surgery
1.2.4 Other
1.3 Market by Application
1.3.1 Global Bacterial Vaginosis Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Diagnostic Laboratories
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Bacterial Vaginosis Therapeutics Market Perspective (2016-2027)
2.2 Bacterial Vaginosis Therapeutics Growth Trends by Regions
2.2.1 Bacterial Vaginosis Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Bacterial Vaginosis Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Bacterial Vaginosis Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Bacterial Vaginosis Therapeutics Industry Dynamic
2.3.1 Bacterial Vaginosis Therapeutics Market Trends
2.3.2 Bacterial Vaginosis Therapeutics Market Drivers
2.3.3 Bacterial Vaginosis Therapeutics Market Challenges
2.3.4 Bacterial Vaginosis Therapeutics Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Bacterial Vaginosis Therapeutics Players by Revenue
3.1.1 Global Top Bacterial Vaginosis Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Bacterial Vaginosis Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Bacterial Vaginosis Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Bacterial Vaginosis Therapeutics Revenue
3.4 Global Bacterial Vaginosis Therapeutics Market Concentration Ratio
3.4.1 Global Bacterial Vaginosis Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Bacterial Vaginosis Therapeutics Revenue in 2020
3.5 Bacterial Vaginosis Therapeutics Key Players Head office and Area Served
3.6 Key Players Bacterial Vaginosis Therapeutics Product Solution and Service
3.7 Date of Enter into Bacterial Vaginosis Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Bacterial Vaginosis Therapeutics Breakdown Data by Type
4.1 Global Bacterial Vaginosis Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Bacterial Vaginosis Therapeutics Forecasted Market Size by Type (2022-2027)

5 Bacterial Vaginosis Therapeutics Breakdown Data by Application
5.1 Global Bacterial Vaginosis Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global Bacterial Vaginosis Therapeutics Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Bacterial Vaginosis Therapeutics Market Size (2016-2027)
6.2 North America Bacterial Vaginosis Therapeutics Market Size by Type
6.2.1 North America Bacterial Vaginosis Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Bacterial Vaginosis Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Bacterial Vaginosis Therapeutics Market Size by Type (2016-2027)
6.3 North America Bacterial Vaginosis Therapeutics Market Size by Application
6.3.1 North America Bacterial Vaginosis Therapeutics Market Size by Application (2016-2021)
6.3.2 North America Bacterial Vaginosis Therapeutics Market Size by Application (2022-2027)
6.3.3 North America Bacterial Vaginosis Therapeutics Market Size by Application (2016-2027)
6.4 North America Bacterial Vaginosis Therapeutics Market Size by Country
6.4.1 North America Bacterial Vaginosis Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Bacterial Vaginosis Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Bacterial Vaginosis Therapeutics Market Size (2016-2027)
7.2 Europe Bacterial Vaginosis Therapeutics Market Size by Type
7.2.1 Europe Bacterial Vaginosis Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Bacterial Vaginosis Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Bacterial Vaginosis Therapeutics Market Size by Type (2016-2027)
7.3 Europe Bacterial Vaginosis Therapeutics Market Size by Application
7.3.1 Europe Bacterial Vaginosis Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe Bacterial Vaginosis Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe Bacterial Vaginosis Therapeutics Market Size by Application (2016-2027)
7.4 Europe Bacterial Vaginosis Therapeutics Market Size by Country
7.4.1 Europe Bacterial Vaginosis Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Bacterial Vaginosis Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Bacterial Vaginosis Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific Bacterial Vaginosis Therapeutics Market Size by Type
8.2.1 Asia-Pacific Bacterial Vaginosis Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Bacterial Vaginosis Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Bacterial Vaginosis Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Bacterial Vaginosis Therapeutics Market Size by Application
8.3.1 Asia-Pacific Bacterial Vaginosis Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Bacterial Vaginosis Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Bacterial Vaginosis Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Bacterial Vaginosis Therapeutics Market Size by Region
8.4.1 Asia-Pacific Bacterial Vaginosis Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Bacterial Vaginosis Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Bacterial Vaginosis Therapeutics Market Size (2016-2027)
9.2 Latin America Bacterial Vaginosis Therapeutics Market Size by Type
9.2.1 Latin America Bacterial Vaginosis Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Bacterial Vaginosis Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Bacterial Vaginosis Therapeutics Market Size by Type (2016-2027)
9.3 Latin America Bacterial Vaginosis Therapeutics Market Size by Application
9.3.1 Latin America Bacterial Vaginosis Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Bacterial Vaginosis Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Bacterial Vaginosis Therapeutics Market Size by Application (2016-2027)
9.4 Latin America Bacterial Vaginosis Therapeutics Market Size by Country
9.4.1 Latin America Bacterial Vaginosis Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Bacterial Vaginosis Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Bacterial Vaginosis Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa Bacterial Vaginosis Therapeutics Market Size by Type
10.2.1 Middle East & Africa Bacterial Vaginosis Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Bacterial Vaginosis Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Bacterial Vaginosis Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Bacterial Vaginosis Therapeutics Market Size by Application
10.3.1 Middle East & Africa Bacterial Vaginosis Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Bacterial Vaginosis Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Bacterial Vaginosis Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Bacterial Vaginosis Therapeutics Market Size by Country
10.4.1 Middle East & Africa Bacterial Vaginosis Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Bacterial Vaginosis Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Bacterial Vaginosis Therapeutics Introduction
11.1.4 Pfizer Revenue in Bacterial Vaginosis Therapeutics Business (2016-2021)
11.1.5 Pfizer Recent Development
11.2 Merck
11.2.1 Merck Company Details
11.2.2 Merck Business Overview
11.2.3 Merck Bacterial Vaginosis Therapeutics Introduction
11.2.4 Merck Revenue in Bacterial Vaginosis Therapeutics Business (2016-2021)
11.2.5 Merck Recent Development
11.3 Novartis
11.3.1 Novartis Company Details
11.3.2 Novartis Business Overview
11.3.3 Novartis Bacterial Vaginosis Therapeutics Introduction
11.3.4 Novartis Revenue in Bacterial Vaginosis Therapeutics Business (2016-2021)
11.3.5 Novartis Recent Development
11.4 Lupin Pharmaceuticals
11.4.1 Lupin Pharmaceuticals Company Details
11.4.2 Lupin Pharmaceuticals Business Overview
11.4.3 Lupin Pharmaceuticals Bacterial Vaginosis Therapeutics Introduction
11.4.4 Lupin Pharmaceuticals Revenue in Bacterial Vaginosis Therapeutics Business (2016-2021)
11.4.5 Lupin Pharmaceuticals Recent Development
11.5 Symbiomix Therapeutics
11.5.1 Symbiomix Therapeutics Company Details
11.5.2 Symbiomix Therapeutics Business Overview
11.5.3 Symbiomix Therapeutics Bacterial Vaginosis Therapeutics Introduction
11.5.4 Symbiomix Therapeutics Revenue in Bacterial Vaginosis Therapeutics Business (2016-2021)
11.5.5 Symbiomix Therapeutics Recent Development
11.6 Mission Pharmacal Company
11.6.1 Mission Pharmacal Company Company Details
11.6.2 Mission Pharmacal Company Business Overview
11.6.3 Mission Pharmacal Company Bacterial Vaginosis Therapeutics Introduction
11.6.4 Mission Pharmacal Company Revenue in Bacterial Vaginosis Therapeutics Business (2016-2021)
11.6.5 Mission Pharmacal Company Recent Development
11.7 Bayer
11.7.1 Bayer Company Details
11.7.2 Bayer Business Overview
11.7.3 Bayer Bacterial Vaginosis Therapeutics Introduction
11.7.4 Bayer Revenue in Bacterial Vaginosis Therapeutics Business (2016-2021)
11.7.5 Bayer Recent Development
11.8 Sanofi
11.8.1 Sanofi Company Details
11.8.2 Sanofi Business Overview
11.8.3 Sanofi Bacterial Vaginosis Therapeutics Introduction
11.8.4 Sanofi Revenue in Bacterial Vaginosis Therapeutics Business (2016-2021)
11.8.5 Sanofi Recent Development
11.9 Starpharma Holdings
11.9.1 Starpharma Holdings Company Details
11.9.2 Starpharma Holdings Business Overview
11.9.3 Starpharma Holdings Bacterial Vaginosis Therapeutics Introduction
11.9.4 Starpharma Holdings Revenue in Bacterial Vaginosis Therapeutics Business (2016-2021)
11.9.5 Starpharma Holdings Recent Development
11.10 Alfa Wassermann
11.10.1 Alfa Wassermann Company Details
11.10.2 Alfa Wassermann Business Overview
11.10.3 Alfa Wassermann Bacterial Vaginosis Therapeutics Introduction
11.10.4 Alfa Wassermann Revenue in Bacterial Vaginosis Therapeutics Business (2016-2021)
11.10.5 Alfa Wassermann Recent Development
11.11 AmVac
11.11.1 AmVac Company Details
11.11.2 AmVac Business Overview
11.11.3 AmVac Bacterial Vaginosis Therapeutics Introduction
11.11.4 AmVac Revenue in Bacterial Vaginosis Therapeutics Business (2016-2021)
11.11.5 AmVac Recent Development
11.12 Evofem
11.12.1 Evofem Company Details
11.12.2 Evofem Business Overview
11.12.3 Evofem Bacterial Vaginosis Therapeutics Introduction
11.12.4 Evofem Revenue in Bacterial Vaginosis Therapeutics Business (2016-2021)
11.12.5 Evofem Recent Development
11.13 Osel
11.13.1 Osel Company Details
11.13.2 Osel Business Overview
11.13.3 Osel Bacterial Vaginosis Therapeutics Introduction
11.13.4 Osel Revenue in Bacterial Vaginosis Therapeutics Business (2016-2021)
11.13.5 Osel Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Bacterial Vaginosis Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Medicine
Table 3. Key Players of Surgery
Table 4. Key Players of Other
Table 5. Global Bacterial Vaginosis Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Bacterial Vaginosis Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Bacterial Vaginosis Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Bacterial Vaginosis Therapeutics Market Share by Regions (2016-2021)
Table 9. Global Bacterial Vaginosis Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Bacterial Vaginosis Therapeutics Market Share by Regions (2022-2027)
Table 11. Bacterial Vaginosis Therapeutics Market Trends
Table 12. Bacterial Vaginosis Therapeutics Market Drivers
Table 13. Bacterial Vaginosis Therapeutics Market Challenges
Table 14. Bacterial Vaginosis Therapeutics Market Restraints
Table 15. Global Bacterial Vaginosis Therapeutics Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Bacterial Vaginosis Therapeutics Market Share by Players (2016-2021)
Table 17. Global Top Bacterial Vaginosis Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bacterial Vaginosis Therapeutics as of 2020)
Table 18. Ranking of Global Top Bacterial Vaginosis Therapeutics Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Bacterial Vaginosis Therapeutics Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Bacterial Vaginosis Therapeutics Product Solution and Service
Table 22. Date of Enter into Bacterial Vaginosis Therapeutics Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Bacterial Vaginosis Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Bacterial Vaginosis Therapeutics Revenue Market Share by Type (2016-2021)
Table 26. Global Bacterial Vaginosis Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Bacterial Vaginosis Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Bacterial Vaginosis Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Bacterial Vaginosis Therapeutics Revenue Market Share by Application (2016-2021)
Table 30. Global Bacterial Vaginosis Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Bacterial Vaginosis Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Bacterial Vaginosis Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Bacterial Vaginosis Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Bacterial Vaginosis Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Bacterial Vaginosis Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Bacterial Vaginosis Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Bacterial Vaginosis Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Bacterial Vaginosis Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Bacterial Vaginosis Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Bacterial Vaginosis Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Bacterial Vaginosis Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Bacterial Vaginosis Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Bacterial Vaginosis Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Bacterial Vaginosis Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Bacterial Vaginosis Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Bacterial Vaginosis Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Bacterial Vaginosis Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Bacterial Vaginosis Therapeutics Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Bacterial Vaginosis Therapeutics Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Bacterial Vaginosis Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Bacterial Vaginosis Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Bacterial Vaginosis Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Bacterial Vaginosis Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Bacterial Vaginosis Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Bacterial Vaginosis Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Bacterial Vaginosis Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Bacterial Vaginosis Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Bacterial Vaginosis Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Bacterial Vaginosis Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Bacterial Vaginosis Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Bacterial Vaginosis Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 62. Pfizer Company Details
Table 63. Pfizer Business Overview
Table 64. Pfizer Bacterial Vaginosis Therapeutics Product
Table 65. Pfizer Revenue in Bacterial Vaginosis Therapeutics Business (2016-2021) & (US$ Million)
Table 66. Pfizer Recent Development
Table 67. Merck Company Details
Table 68. Merck Business Overview
Table 69. Merck Bacterial Vaginosis Therapeutics Product
Table 70. Merck Revenue in Bacterial Vaginosis Therapeutics Business (2016-2021) & (US$ Million)
Table 71. Merck Recent Development
Table 72. Novartis Company Details
Table 73. Novartis Business Overview
Table 74. Novartis Bacterial Vaginosis Therapeutics Product
Table 75. Novartis Revenue in Bacterial Vaginosis Therapeutics Business (2016-2021) & (US$ Million)
Table 76. Novartis Recent Development
Table 77. Lupin Pharmaceuticals Company Details
Table 78. Lupin Pharmaceuticals Business Overview
Table 79. Lupin Pharmaceuticals Bacterial Vaginosis Therapeutics Product
Table 80. Lupin Pharmaceuticals Revenue in Bacterial Vaginosis Therapeutics Business (2016-2021) & (US$ Million)
Table 81. Lupin Pharmaceuticals Recent Development
Table 82. Symbiomix Therapeutics Company Details
Table 83. Symbiomix Therapeutics Business Overview
Table 84. Symbiomix Therapeutics Bacterial Vaginosis Therapeutics Product
Table 85. Symbiomix Therapeutics Revenue in Bacterial Vaginosis Therapeutics Business (2016-2021) & (US$ Million)
Table 86. Symbiomix Therapeutics Recent Development
Table 87. Mission Pharmacal Company Company Details
Table 88. Mission Pharmacal Company Business Overview
Table 89. Mission Pharmacal Company Bacterial Vaginosis Therapeutics Product
Table 90. Mission Pharmacal Company Revenue in Bacterial Vaginosis Therapeutics Business (2016-2021) & (US$ Million)
Table 91. Mission Pharmacal Company Recent Development
Table 92. Bayer Company Details
Table 93. Bayer Business Overview
Table 94. Bayer Bacterial Vaginosis Therapeutics Product
Table 95. Bayer Revenue in Bacterial Vaginosis Therapeutics Business (2016-2021) & (US$ Million)
Table 96. Bayer Recent Development
Table 97. Sanofi Company Details
Table 98. Sanofi Business Overview
Table 99. Sanofi Revenue in Bacterial Vaginosis Therapeutics Business (2016-2021) & (US$ Million)
Table 100. Sanofi Recent Development
Table 101. Starpharma Holdings Company Details
Table 102. Starpharma Holdings Business Overview
Table 103. Starpharma Holdings Bacterial Vaginosis Therapeutics Product
Table 104. Starpharma Holdings Revenue in Bacterial Vaginosis Therapeutics Business (2016-2021) & (US$ Million)
Table 105. Starpharma Holdings Recent Development
Table 106. Alfa Wassermann Company Details
Table 107. Alfa Wassermann Business Overview
Table 108. Alfa Wassermann Bacterial Vaginosis Therapeutics Product
Table 109. Alfa Wassermann Revenue in Bacterial Vaginosis Therapeutics Business (2016-2021) & (US$ Million)
Table 110. Alfa Wassermann Recent Development
Table 111. AmVac Company Details
Table 112. AmVac Business Overview
Table 113. AmVac Bacterial Vaginosis Therapeutics Product
Table 114. AmVac Revenue in Bacterial Vaginosis Therapeutics Business (2016-2021) & (US$ Million)
Table 115. AmVac Recent Development
Table 116. Evofem Company Details
Table 117. Evofem Business Overview
Table 118. Evofem Bacterial Vaginosis Therapeutics Product
Table 119. Evofem Revenue in Bacterial Vaginosis Therapeutics Business (2016-2021) & (US$ Million)
Table 120. Evofem Recent Development
Table 121. Osel Company Details
Table 122. Osel Business Overview
Table 123. Osel Bacterial Vaginosis Therapeutics Product
Table 124. Osel Revenue in Bacterial Vaginosis Therapeutics Business (2016-2021) & (US$ Million)
Table 125. Osel Recent Development
Table 126. Research Programs/Design for This Report
Table 127. Key Data Information from Secondary Sources
Table 128. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Bacterial Vaginosis Therapeutics Market Share by Type: 2020 VS 2027
Figure 2. Medicine Features
Figure 3. Surgery Features
Figure 4. Other Features
Figure 5. Global Bacterial Vaginosis Therapeutics Market Share by Application: 2020 VS 2027
Figure 6. Hospitals Case Studies
Figure 7. Clinics Case Studies
Figure 8. Diagnostic Laboratories Case Studies
Figure 9. Other Case Studies
Figure 10. Bacterial Vaginosis Therapeutics Report Years Considered
Figure 11. Global Bacterial Vaginosis Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Bacterial Vaginosis Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Bacterial Vaginosis Therapeutics Market Share by Regions: 2020 VS 2027
Figure 14. Global Bacterial Vaginosis Therapeutics Market Share by Regions (2022-2027)
Figure 15. Global Bacterial Vaginosis Therapeutics Market Share by Players in 2020
Figure 16. Global Top Bacterial Vaginosis Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bacterial Vaginosis Therapeutics as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Bacterial Vaginosis Therapeutics Revenue in 2020
Figure 18. Global Bacterial Vaginosis Therapeutics Revenue Market Share by Type (2016-2021)
Figure 19. Global Bacterial Vaginosis Therapeutics Revenue Market Share by Type (2022-2027)
Figure 20. North America Bacterial Vaginosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Bacterial Vaginosis Therapeutics Market Share by Type (2016-2027)
Figure 22. North America Bacterial Vaginosis Therapeutics Market Share by Application (2016-2027)
Figure 23. North America Bacterial Vaginosis Therapeutics Market Share by Country (2016-2027)
Figure 24. United States Bacterial Vaginosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Bacterial Vaginosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Bacterial Vaginosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Bacterial Vaginosis Therapeutics Market Share by Type (2016-2027)
Figure 28. Europe Bacterial Vaginosis Therapeutics Market Share by Application (2016-2027)
Figure 29. Europe Bacterial Vaginosis Therapeutics Market Share by Country (2016-2027)
Figure 30. Germany Bacterial Vaginosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Bacterial Vaginosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Bacterial Vaginosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Bacterial Vaginosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Bacterial Vaginosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Bacterial Vaginosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Bacterial Vaginosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Bacterial Vaginosis Therapeutics Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Bacterial Vaginosis Therapeutics Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Bacterial Vaginosis Therapeutics Market Share by Region (2016-2027)
Figure 40. China Bacterial Vaginosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Bacterial Vaginosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Bacterial Vaginosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Bacterial Vaginosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Bacterial Vaginosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Bacterial Vaginosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Bacterial Vaginosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Bacterial Vaginosis Therapeutics Market Share by Type (2016-2027)
Figure 48. Latin America Bacterial Vaginosis Therapeutics Market Share by Application (2016-2027)
Figure 49. Latin America Bacterial Vaginosis Therapeutics Market Share by Country (2016-2027)
Figure 50. Mexico Bacterial Vaginosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Bacterial Vaginosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Bacterial Vaginosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Bacterial Vaginosis Therapeutics Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Bacterial Vaginosis Therapeutics Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Bacterial Vaginosis Therapeutics Market Share by Country (2016-2027)
Figure 56. Turkey Bacterial Vaginosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Bacterial Vaginosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Bacterial Vaginosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Pfizer Revenue Growth Rate in Bacterial Vaginosis Therapeutics Business (2016-2021)
Figure 60. Merck Revenue Growth Rate in Bacterial Vaginosis Therapeutics Business (2016-2021)
Figure 61. Novartis Revenue Growth Rate in Bacterial Vaginosis Therapeutics Business (2016-2021)
Figure 62. Lupin Pharmaceuticals Revenue Growth Rate in Bacterial Vaginosis Therapeutics Business (2016-2021)
Figure 63. Symbiomix Therapeutics Revenue Growth Rate in Bacterial Vaginosis Therapeutics Business (2016-2021)
Figure 64. Mission Pharmacal Company Revenue Growth Rate in Bacterial Vaginosis Therapeutics Business (2016-2021)
Figure 65. Bayer Revenue Growth Rate in Bacterial Vaginosis Therapeutics Business (2016-2021)
Figure 66. Sanofi Revenue Growth Rate in Bacterial Vaginosis Therapeutics Business (2016-2021)
Figure 67. Starpharma Holdings Revenue Growth Rate in Bacterial Vaginosis Therapeutics Business (2016-2021)
Figure 68. Alfa Wassermann Revenue Growth Rate in Bacterial Vaginosis Therapeutics Business (2016-2021)
Figure 69. AmVac Revenue Growth Rate in Bacterial Vaginosis Therapeutics Business (2016-2021)
Figure 70. Evofem Revenue Growth Rate in Bacterial Vaginosis Therapeutics Business (2016-2021)
Figure 71. Osel Revenue Growth Rate in Bacterial Vaginosis Therapeutics Business (2016-2021)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed

以下、関連資料のご紹介

世界の細菌性膣炎治療市場規模・現状・予測（2021年-2027年）

Global Bacterial Vaginosis Treatment Market Size, Status and Forecast 2021-2027
QFJ1-3887 2021年6月 123Pages
QYResearch社発行の本調査レポートでは、細菌性膣炎治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（外科手術治療、薬物治療）、用途別市場規模（病院、専門治療センター、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、...

世界のグラム陰性菌感染症治療薬市場規模・現状・予測（2021年-2027年）

Global Gram-Negative Bacterial Infection Therapeutics Market Size, Status and Forecast 2021-2027
QFJ1-4272 2021年6月 95Pages
QYResearch社発行の本調査レポートでは、グラム陰性菌感染症治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（経腸治療、非経口治療、局所治療）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本...

細菌性膣炎治療薬のグローバル市場2021

Global Bacterial Vaginosis Drug Sales Market Report 2021
QAF27582 2021年4月7日 148Pages
本市場調査資料では、世界の細菌性膣炎治療薬市場について種類別（Rx、OTC）、用途別（病院、薬局、その他）、地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2016年～2027年までの市場規模と予測（販売量、売上、価格）、主要プレイヤーの競争状況・市場シェ...

世界の急性細菌性皮膚＆皮膚組織感染症（ABSSSI）治療市場規模・現状・予測（2021年-2027年）

Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size, Status and Forecast 2021-2027
QFJ1-3756 2021年6月 127Pages
QYResearch社発行の本調査レポートでは、急性細菌性皮膚＆皮膚組織感染症（ABSSSI）治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（デラフロキサシン、バンコマイシン、セフタロリンフォサミル、その他）、用途別市場規模（蜂巣炎、膿瘍、外科...

世界の多剤耐性細菌感染症治療市場規模・現状・予測（2021年-2027年）

Global Multiple Drug Resistance Bacterial Infection Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4533 2021年6月 117Pages
QYResearch社発行の本調査レポートでは、多剤耐性細菌感染症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（クリティカル、ミディアム、ハイ）、用途別市場規模（セファロスポリン、ベータラクタム、ベータラクタマーゼ阻害剤、オキサゾリジノン、環...

世界の水産養殖における細菌診断市場規模・現状・予測（2021年-2027年）

Global Bacterial Diagnostics in Aquaculture Market Size, Status and Forecast 2021-2027
QFJ1-3884 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、水産養殖における細菌診断の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（分子診断、蛍光抗体検査、ポリメラーゼ連鎖反応、その他）、用途別市場規模（一般養殖、特別養殖）、主要地域別市場規模（北米、アメリカ...

世界の細菌感染症診断市場規模・現状・予測（2021年-2027年）

Global Bacterial Disease Diagnostics Market Size, Status and Forecast 2021-2027
QFJ1-3885 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、細菌感染症診断の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（機器、消耗品、その他）、用途別市場規模（臨床、腸チフス、マラリア、結核（TB）、結核性髄膜炎、その他）、主要地域別市場規模（北米、アメリカ...

世界の細菌性エンドトキシン検査市場規模・現状・予測（2021年-2027年）

Global Bacterial Endotoxin Testing Market Size, Status and Forecast 2021-2027
QFJ1-3886 2021年6月 106Pages
QYResearch社発行の本調査レポートでは、細菌性エンドトキシン検査の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ゲルクロットエンドトキシン検査、クロロゲン酸エンドトキシン検査、タービディメトリックエンドトキシン検査）、用途別市場規模（医薬品...

世界の土着細菌＆ウイルス抗原市場規模・現状・予測（2021年-2027年）

Global Native Bacterial and Viral Antigens Market Size, Status and Forecast 2021-2027
QFJ1-4552 2021年6月 106Pages
QYResearch社発行の本調査レポートでは、土着細菌＆ウイルス抗原の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（クラミディア抗原、アデノウイルス抗原、ボレリア抗原、チクングニアウイルス抗原、クロストリジウム抗原、デングウイルス抗原）、用途別市...

世界のCOPD治療薬市場規模・現状・予測（2021年-2027年）

Global COPD Therapeutics Market Size, Status and Forecast 2021-2027
QFJ1-5676 2021年6月 89Pages
QYResearch社発行の本調査レポートでは、COPD治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（気管支拡張薬、吸入コルチコステロイド、その他）、用途別市場規模（大人用、子供用）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、...

世界の細菌性膣炎治療市場規模・現状・予測（2021年-2027年） Bacterial vaginosis (BV) is a common vaginal infection.Is one of the most widely studied obstetric/gynecological infectious diseases.An infection associated with a group of pathogenic anaerobic microorganisms rather than a specific pathogen.This includes surgery and medication.Bacterial vaginosis is…
細菌性膣炎治療薬のグローバル市場2021 Bacterial Vaginosis Drug is used for the treatment of Bacterial Vaginosis (BV), which also known as vaginal bacteriosis or Gardnerella vaginitis, a disease of the vagina caused by excessive bacteria. The classification of bacterial vaginosis drug includes Rx and OTC, and the proportion of OTC in 201…
世界のグラム陰性菌感染症治療薬市場規模・現状・予測（2021年-2027年） Gram-negative bacteria generally refer to bacteria that show red in the gram-negative staining reaction. Market Analysis and Insights: Global Gram-Negative Bacterial Infection Therapeutics Market The global Gram-Negative Bacterial Infection Therapeutics market size is projected to reach US$ XX milli…
グラム陰性菌感染症治療薬のグローバル市場：規模・現状・予測2019-2025 Gram-negative bacteria generally refer to bacteria that show red in the gram-negative staining reaction.In 2018, the global Gram-Negative Bacterial Infection Therapeutics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025…
グラム陰性菌感染症治療薬のグローバル市場：規模・現状・予測2019-2025 Gram-negative bacteria generally refer to bacteria that show red in the gram-negative staining reaction.In 2018, the global Gram-Negative Bacterial Infection Therapeutics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025…